APA (7th ed.) Citation

Wang, M., Peng, Y., Yan, H., Pan, Z., Du, R., & Liu, G. (2025). Bioequivalence and Safety of Two Amisulpride Formulations in Healthy Chinese Subjects Under Fasting and Fed Conditions: A Randomized, Open‑Label, Single‑Dose, Crossover Study. Drugs in R&D, 25(2), 117-125. https://doi.org/10.1007/s40268-025-00508-7

Chicago Style (17th ed.) Citation

Wang, Min, Yu Peng, Hegui Yan, Zhixiang Pan, Ronghui Du, and Guan Liu. "Bioequivalence and Safety of Two Amisulpride Formulations in Healthy Chinese Subjects Under Fasting and Fed Conditions: A Randomized, Open‑Label, Single‑Dose, Crossover Study." Drugs in R&D 25, no. 2 (2025): 117-125. https://doi.org/10.1007/s40268-025-00508-7.

MLA (9th ed.) Citation

Wang, Min, et al. "Bioequivalence and Safety of Two Amisulpride Formulations in Healthy Chinese Subjects Under Fasting and Fed Conditions: A Randomized, Open‑Label, Single‑Dose, Crossover Study." Drugs in R&D, vol. 25, no. 2, 2025, pp. 117-125, https://doi.org/10.1007/s40268-025-00508-7.